跳至主要内容
临床试验/JPRN-UMIN000025801
JPRN-UMIN000025801招募中未知

A randomized controlled trial comparing Vonoprazan, Amoxicillin, Metronidazole triple therapy and Rabeprazole, Amoxicillin, Metronidazole triple therapy as a second-line eradication of Helicobacter pylori - RCT comparing VAM and RAM HP eradication as second-line

Yokohama City University Hospital0 个研究点目标入组 80 人开始时间: 2017年1月24日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • A patient who has eradication history except triple therapy with Vonoprazan, Amoxicillin and Clarithromycin. Pregnancy or lactation. Past history of allergy for the drugs used in this study. A patient with brain and spinal cord disease. A patient with infectious mononucleosis. Severe liver dysfunction, severe renal dysfunction, severe heart dysfunction. Patient who is disqualified for the study by physicians.

研究者

相似试验

A randomized controlled trial comparing Vonoprazan,... | 临床试验